Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ONYX-015 combination enters phase II; U.S. patent awarded

Oct. 15, 1997

St. Jude researchers discover new role for p53

Oct. 14, 1997

Pharmacia & Upjohn discloses new distamycin derivatives

Oct. 14, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

Improved efficacy of MEN-10755 related to apoptosis?

Oct. 13, 1997

DUROS leuprolide enters phase III for prostate cancer

Oct. 10, 1997

Demeter BioTechnologies awarded grant for cancer therapeutics program

Oct. 10, 1997

Progress made on MMAC-1 research; Schering-Plough acquires rights to therapies

Oct. 10, 1997

Selective iNOS inhibitor inhibits tumor growth in mice

Oct. 10, 1997

New immunotherapy for metastatic tumors reported

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...